ExodusPoint Capital Management’s Inozyme Pharma INZY Stock Holding History

ExodusPoint Capital Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,515	Closed	-$222K	–	1765
2025 Q2	$222K	Buy	+55,515	New	+$137K	﹤0.01%	1298
2024 Q4	–	Sell	-48,056	Closed	-$251K	–	1757
2024 Q3	$251K	Sell	48,056 -7,130	-13%	-$37K	﹤0.01%	1410
2024 Q2	$246K	Buy	+55,186	New	+$268K	﹤0.01%	1360
2023 Q3	–	Sell	-22,081	Closed	-$123K	–	1907
2023 Q2	$123K	Buy	+22,081	New	+$131K	﹤0.01%	1742

ExodusPoint Capital Management's INZY Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 55,515 shares — an estimated $222K sold.

ExodusPoint Capital Management first reported a position in INZY in Q2 2023 and held it in 4 quarters. The position peaked at $251K in Q3 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

ExodusPoint Capital Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 55,515 Inozyme Pharma shares in Q3 2025, an estimated $222K.
ExodusPoint Capital Management first reported a position in Inozyme Pharma in Q2 2023 and held it in 4 quarters.
ExodusPoint Capital Management's Inozyme Pharma position peaked at $251K in Q3 2024.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.